skip to main content
Idioma:
Refinado por: Nome da Publicação: Leukemia remover assunto: Middle Aged remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes

Falconi, Giulia ; Fabiani, Emiliano ; Piciocchi, Alfonso ; Criscuolo, Marianna ; Fianchi, Luana ; Lindfors Rossi, Elisa L ; Finelli, Carlo ; Cerqui, Elisa ; Ottone, Tiziana ; Molteni, Alfredo ; Parma, Matteo ; Santarone, Stella ; Candoni, Anna ; Sica, Simona ; Leone, Giuseppe ; Lo-Coco, Francesco ; Voso, Maria Teresa

Leukemia, 2019-03, Vol.33 (3), p.785-790 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial

Rossille, D ; Gressier, M ; Damotte, D ; Maucort-Boulch, D ; Pangault, C ; Semana, G ; Le Gouill, S ; Haioun, C ; Tarte, K ; Lamy, T ; Milpied, N ; Fest, T

Leukemia, 2014-12, Vol.28 (12), p.2367-2375 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)
A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)
Material Type:
Artigo 		Adicionar ao Meu Espaço

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

Hájek, R ; Masszi, T ; Petrucci, M T ; Palumbo, A ; Rosiñol, L ; Nagler, A ; Yong, K L ; Oriol, A ; Minarik, J ; Pour, L ; Dimopoulos, M A ; Maisnar, V ; Rossi, D ; Kasparu, H ; Van Droogenbroeck, J ; Yehuda, D B ; Hardan, I ; Jenner, M ; Calbecka, M ; Dávid, M ; de la Rubia, J ; Drach, J ; Gasztonyi, Z ; Górnik, S ; Leleu, X ; Munder, M ; Offidani, M ; Zojer, N ; Rajangam, K ; Chang, Y-L ; San-Miguel, J F ; Ludwig, H

Leukemia, 2017-01, Vol.31 (1), p.107-114 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib

Castagnetti, F ; Gugliotta, G ; Breccia, M ; Stagno, F ; Iurlo, A ; Albano, F ; Abruzzese, E ; Martino, B ; Levato, L ; Intermesoli, T ; Pregno, P ; Rossi, G ; Gherlinzoni, F ; Leoni, P ; Cavazzini, F ; Venturi, C ; Soverini, S ; Testoni, N ; Alimena, G ; Cavo, M ; Martinelli, G ; Pane, F ; Saglio, G ; Rosti, G ; Baccarani, M

Leukemia, 2015-09, Vol.29 (9), p.1823-1831 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists
High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists
Material Type:
Artigo 		Adicionar ao Meu Espaço

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists

De Stefano, V ; Ruggeri, M ; Cervantes, F ; Alvarez-Larrán, A ; Iurlo, A ; Randi, M L ; Elli, E ; Finazzi, M C ; Finazzi, G ; Zetterberg, E ; Vianelli, N ; Gaidano, G ; Rossi, E ; Betti, S ; Nichele, I ; Cattaneo, D ; Palova, M ; Ellis, M H ; Cacciola, R ; Tieghi, A ; Hernandez-Boluda, J C ; Pungolino, E ; Specchia, G ; Rapezzi, D ; Forcina, A ; Musolino, C ; Carobbio, A ; Griesshammer, M ; Sant'Antonio, E ; Vannucchi, A M ; Barbui, T

Leukemia, 2016-10, Vol.30 (10), p.2032-2038 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma

Corradini, P ; Vitolo, U ; Rambaldi, A ; Miceli, R ; Patriarca, F ; Gallamini, A ; Olivieri, A ; Benedetti, F ; Todeschini, G ; Rossi, G ; Salvi, F ; Bruno, B ; Baldini, L ; Ferreri, A ; Patti, C ; Tarella, C ; Pileri, S ; Dodero, A

Leukemia, 2014-09, Vol.28 (9), p.1885-1891 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma

Dodero, A ; Guidetti, A ; Tucci, A ; Barretta, F ; Novo, M ; Devizzi, L ; Re, A ; Passi, A ; Pellegrinelli, A ; Pruneri, G ; Miceli, R ; Testi, A ; Pennisi, M ; Di Chio, M C ; Matteucci, P ; Carniti, C ; Facchetti, F ; Rossi, G ; Corradini, P

Leukemia, 2019-04, Vol.33 (4), p.1047-1051 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System
Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System
Material Type:
Artigo 		Adicionar ao Meu Espaço

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System

Della Porta, M G ; Jackson, C H ; Alessandrino, E P ; Rossi, M ; Bacigalupo, A ; van Lint, M T ; Bernardi, M ; Allione, B ; Bosi, A ; Guidi, S ; Santini, V ; Malcovati, L ; Ubezio, M ; Milanesi, C ; Todisco, E ; Voso, M T ; Musto, P ; Onida, F ; Iori, A P ; Cerretti, R ; Grillo, G ; Molteni, A ; Pioltelli, P ; Borin, L ; Angelucci, E ; Oldani, E ; Sica, S ; Pascutto, C ; Ferretti, V ; Santoro, A ; Bonifazi, F ; Cazzola, M ; Rambaldi, A

Leukemia, 2017-11, Vol.31 (11), p.2449-2457 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease

Mauro, F R ; Chauvie, S ; Paoloni, F ; Biggi, A ; Cimino, G ; Rago, A ; Gentile, M ; Morabito, F ; Coscia, M ; Bellò, M ; Sacchetti, G M ; Rossi, D ; Laurenti, L ; Autore, F ; Campanelli, M ; Trastulli, F ; Nicolai, E ; Riminucci, M ; Gaidano, G ; Guarini, A ; Gallamini, A ; Foà, R

Leukemia, 2015-06, Vol.29 (6), p.1360-1365 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
Material Type:
Artigo 		Adicionar ao Meu Espaço

Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21

ROSSI, D ; RASI, S ; KWEE, I ; BERTONI, F ; CONCONI, A ; GAIDANO, G ; FRANCESCHETTJ, S ; CAPELLO, D ; CASTELLI, A ; DE PAOLI, L ; RAMPONI, A ; CHIAPPELLA, A ; POGLIANI, E. M ; VITOLO, U

Leukemia, 2009-06, Vol.23 (6), p.1118-1126 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.